From DSM to ICN
Executive Summary
Former DSM Pharmaceuticals CEO Wesley Wheeler is named North American president of ICN Pharmaceuticals. Company notes that Wheeler has experience with "business turnarounds," cites his tenure at DSM. Wheeler joined the contract manufacturing firm as part of a management overhaul following several problematic FDA inspections. Prior to joining DSM, Wheeler was senior VP-logistics & strategy for GlaxoSmithKline (1"The Pink Sheet" Sept. 30, 2002, p. 30)...